These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 26010860

  • 1. Fatty acid metabolism and its longitudinal relationship with the hypothalamic-pituitary-adrenal axis in major depression: Associations with prospective antidepressant response.
    Mocking RJ, Verburg HF, Westerink AM, Assies J, Vaz FM, Koeter MW, Ruhé HG, Schene AH.
    Psychoneuroendocrinology; 2015 Sep; 59():1-13. PubMed ID: 26010860
    [Abstract] [Full Text] [Related]

  • 2. Relationship between the hypothalamic-pituitary-adrenal-axis and fatty acid metabolism in recurrent depression.
    Mocking RJ, Ruhé HG, Assies J, Lok A, Koeter MW, Visser I, Bockting CL, Schene AH.
    Psychoneuroendocrinology; 2013 Sep; 38(9):1607-17. PubMed ID: 23465556
    [Abstract] [Full Text] [Related]

  • 3. Cortisol, dehydroepiandrosterone sulfate, fatty acids, and their relation in recurrent depression.
    Ter Horst DM, Schene AH, Figueroa CA, Assies J, Lok A, Bockting CLH, Ruhé HG, Mocking RJT.
    Psychoneuroendocrinology; 2019 Feb; 100():203-212. PubMed ID: 30388594
    [Abstract] [Full Text] [Related]

  • 4. Biological profiling of prospective antidepressant response in major depressive disorder: Associations with (neuro)inflammation, fatty acid metabolism, and amygdala-reactivity.
    Mocking RJT, Nap TS, Westerink AM, Assies J, Vaz FM, Koeter MWJ, Ruhé HG, Schene AH.
    Psychoneuroendocrinology; 2017 May; 79():84-92. PubMed ID: 28262603
    [Abstract] [Full Text] [Related]

  • 5. DHEAS and cortisol/DHEAS-ratio in recurrent depression: State, or trait predicting 10-year recurrence?
    Mocking RJ, Pellikaan CM, Lok A, Assies J, Ruhé HG, Koeter MW, Visser I, Bockting CL, Olff M, Schene AH.
    Psychoneuroendocrinology; 2015 Sep; 59():91-101. PubMed ID: 26036454
    [Abstract] [Full Text] [Related]

  • 6. Longitudinal effects of the SSRI paroxetine on salivary cortisol in Major Depressive Disorder.
    Ruhé HG, Khoenkhoen SJ, Ottenhof KW, Koeter MW, Mocking RJ, Schene AH.
    Psychoneuroendocrinology; 2015 Feb; 52():261-71. PubMed ID: 25544738
    [Abstract] [Full Text] [Related]

  • 7. Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression.
    Lok A, Mocking RJ, Ruhé HG, Visser I, Koeter MW, Assies J, Bockting CL, Olff M, Schene AH.
    Psychoneuroendocrinology; 2012 Jul; 37(7):892-902. PubMed ID: 22094110
    [Abstract] [Full Text] [Related]

  • 8. Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine.
    Weber-Hamann B, Gilles M, Lederbogen F, Heuser I, Deuschle M.
    J Clin Psychiatry; 2006 Dec; 67(12):1856-61. PubMed ID: 17194262
    [Abstract] [Full Text] [Related]

  • 9. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 10. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
    Aihara M, Ida I, Yuuki N, Oshima A, Kumano H, Takahashi K, Fukuda M, Oriuchi N, Endo K, Matsuda H, Mikuni M.
    Psychiatry Res; 2007 Aug 15; 155(3):245-56. PubMed ID: 17587554
    [Abstract] [Full Text] [Related]

  • 11. Hair cortisol as a marker of hypothalamic-pituitary-adrenal Axis activity in female patients with major depressive disorder.
    Pochigaeva K, Druzhkova T, Yakovlev A, Onufriev M, Grishkina M, Chepelev A, Guekht A, Gulyaeva N.
    Metab Brain Dis; 2017 Apr 15; 32(2):577-583. PubMed ID: 28064407
    [Abstract] [Full Text] [Related]

  • 12. Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: The role of remission status.
    Salvat-Pujol N, Labad J, Urretavizcaya M, de Arriba-Arnau A, Segalàs C, Real E, Ferrer A, Crespo JM, Jiménez-Murcia S, Soriano-Mas C, Menchón JM, Soria V.
    Psychoneuroendocrinology; 2017 Feb 15; 76():38-48. PubMed ID: 27883963
    [Abstract] [Full Text] [Related]

  • 13. Effects of rapid tryptophan depletion on salivary cortisol in older people recovered from depression, and the healthy elderly.
    Porter RJ, Gallagher P, O'Brien JT.
    J Psychopharmacol; 2007 Jan 15; 21(1):71-5. PubMed ID: 16533861
    [Abstract] [Full Text] [Related]

  • 14. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
    Psychoneuroendocrinology; 2009 Jan 15; 34(1):99-109. PubMed ID: 18829172
    [Abstract] [Full Text] [Related]

  • 15. Diurnal Hypothalamic-Pituitary-Adrenal Axis Measures and Inflammatory Marker Correlates in Major Depressive Disorder.
    Doolin K, Farrell C, Tozzi L, Harkin A, Frodl T, O'Keane V.
    Int J Mol Sci; 2017 Oct 24; 18(10):. PubMed ID: 29064428
    [Abstract] [Full Text] [Related]

  • 16. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
    Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, Smit JH, Zitman FG, Penninx BW.
    Arch Gen Psychiatry; 2009 Jun 24; 66(6):617-26. PubMed ID: 19487626
    [Abstract] [Full Text] [Related]

  • 17. Levels and variability of daily life cortisol secretion in major depression.
    Peeters F, Nicolson NA, Berkhof J.
    Psychiatry Res; 2004 Apr 15; 126(1):1-13. PubMed ID: 15081622
    [Abstract] [Full Text] [Related]

  • 18. Cortisol, moderated by age, is associated with antidepressant treatment outcome and memory improvement in Major Depressive Disorder: A retrospective analysis.
    Jain FA, Connolly CG, Reus VI, Meyerhoff DJ, Yang TT, Mellon SH, Mackin S, Hough CM, Morford A, Wolkowitz OM.
    Psychoneuroendocrinology; 2019 Nov 15; 109():104386. PubMed ID: 31382170
    [Abstract] [Full Text] [Related]

  • 19. In search of the HPA axis activity in unipolar depression patients with childhood trauma: Combined cortisol awakening response and dexamethasone suppression test.
    Lu S, Gao W, Huang M, Li L, Xu Y.
    J Psychiatr Res; 2016 Jul 15; 78():24-30. PubMed ID: 27049575
    [Abstract] [Full Text] [Related]

  • 20. RELATIONSHIP BETWEEN THE CORTICAL THICKNESS AND SERUM CORTISOL LEVELS IN DRUG-NAÏVE, FIRST-EPISODE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SURFACE-BASED MORPHOMETRIC STUDY.
    Liu X, Kakeda S, Watanabe K, Yoshimura R, Abe O, Ide S, Hayashi K, Katsuki A, Umeno-Nakano W, Watanabe R, Ueda I, Moriya J, Nakamura J, Korogi Y.
    Depress Anxiety; 2015 Sep 15; 32(9):702-8. PubMed ID: 26290363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.